Jelena Osmanovic Barilar

Jelena Osmanovic Barilar

Auto-generated profile, based on publicly available information

Jelena Osmanovic Barilar

Department of Pharmacology, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2014 in Journal of Neural Transmission
Verified
Journal Article
Closed access
PDF file
JBJ. Osmanovic Barilar
J. Osmanovic Barilar
AKAna Knezovic
Ana Knezovic
EGEdna Grünblatt
Edna Grünblatt
PRP. Riederer
P. Riederer
MSM. Salkovic-Petrisic
M. Salkovic-Petrisic

24 December 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
Jan HomolakJan Homolak
Jan Homolak
Ana Babic PerhocAna Babic Perhoc
Ana Babic Perhoc
AKAna Knezovic
Ana Knezovic
JBJelena Osmanovic Barilar
Jelena Osmanovic Barilar
DVDavor Virag
Davor Virag
MSMelita Salkovic-Petrisic
Melita Salkovic-Petrisic
Galactose is a ubiquitous monosaccharide with important yet incompletely understood nutritive and physiological roles. Chronic parenteral d-galactose administration is used for modeling aging-related pathophysiological processes in rodents due to its ability to induce oxidative stress (OS). Conversely, chronic oral d-galactose administration prevents and alleviates cognitive decline in a rat model of sporadic Alzheimer’s disease, indicating that galactose may exert beneficial health effects by acting in the gut. The present aim was to explore the acute time-response of intestinal redox homeostasis following oral administration of d-galactose. Male Wistar rats were euthanized at baseline (n = 6), 30 (n = 6), 60 (n = 6), and 120 (n = 6) minutes following orogastric administration of d-galactose (200 mg/kg). The overall reductive capacity, lipid peroxidation, the concentration of low-molecular-weight thiols (LMWT) and protein sulfhydryls (SH), the activity of Mn and Cu/Zn superoxide dismutases (SOD), reduced and oxidized fractions of nicotinamide adenine dinucleotide phosphates (NADPH/NADP), and the hydrogen peroxide dissociation rate were analyzed in duodenum and ileum. Acute oral administration of d-galactose increased the activity of SODs and decreased intestinal lipid peroxidation and nucleophilic substrates (LMWT, SH, NADPH), indicating activation of peroxidative damage defense pathways. The redox system of the small intestine can acutely tolerate even high luminal concentrations of galactose (0.55 M), and oral galactose treatment is associated with a reduction rather than the increment of the intestinal OS. The ability of oral d-galactose to modulate intestinal OS should be further explored in the context of intestinal barrier maintenance, and beneficial cognitive effects associated with long-term administration of low doses of d-galactose.

Verified
Journal Article
Open access
PDF file
JBJelena Osmanovic Barilar
Jelena Osmanovic Barilar
AKAna Knezovic
Ana Knezovic
Jan HomolakJan Homolak
Jan Homolak
Ana Babic PerhocAna Babic Perhoc
Ana Babic Perhoc
MSMelita Salkovic-Petrisic
Melita Salkovic-Petrisic
The incretin system is an emerging new field that might provide valuable contributions to the research of both the pathophysiology and therapeutic strategies in the treatment of diabetes, obesity, and neurodegenerative disorders. This study aimed to explore the roles of central glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide (GIP) on cell metabolism and energy in the brain, as well as on the levels of these incretins, insulin, and glucose via inhibition of the central incretin receptors following intracerebroventricular administration of the respective antagonists in healthy rats and a streptozotocin-induced rat model of sporadic Alzheimer’s disease (sAD). Chemical ablation of the central GIP receptor (GIPR) or GLP-1 receptor (GLP-1R) in healthy and diseased animals indicated a region-dependent role of incretins in brain cell energy and metabolism and central incretin-dependent modulation of peripheral hormone secretion, markedly after GIPR inhibition, as well as a dysregulation of the GLP-1 system in experimental sAD.